Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
1.
Acta sci. vet. (Impr.) ; 49(supl.1): 705, 2021. ilus
Article in Portuguese | VETINDEX | ID: biblio-1363624

ABSTRACT

Background: Cenurosis is a parasitic disease caused by Coenurus cerebralis, an intermediate form of Taenia multiceps multiceps, causing a fatal disease in production animals. Its adult form (Taenia) lodges in the small intestine of canids and can infect several intermediate hosts. Sheep are the main species affected by the disease, having nervous symptoms as one of its manifestations. This study aimed to describe the changes observed in computed tomography, as well as the clinical findings of a case of Cenurosis in a sheep on the western border of Rio Grande do Sul. Case: A ram was referred to the Centro Universitário da Região da Campanha (URCAMP) with neurological signs. Clinical, hematological, radiographic, tomographic and necroscopic evaluation of the animal was performed. There were no significant hematological and radiographic changes. During the neurological examination, corneal opacity was found in the right eyeball, associated with a visual deficit in the same eye. Also, when stimulated to move, it was possible to observe ataxia with ambulation to the left side, with right lateral displacement of the head. The tomography showed a hypodense area of approximately 3 cm at the base of the brain, in the region of the thalamus and third ventricle. Macroscopically, a translucent spherical cyst with approximately 4 cm in diameter was observed, containing the protoescolex/scolices of Taenia multiceps in the same region. Discussion: Computed tomography identified the presence of an apparently circular volume of approximately 4 cm in diameter, causing ventricular dilatation. This evidence of ventricular dilation corroborates aspects described in the literature, which found bilateral dilation of the ventricles by compression promoted by a cyst in the 4th ventricle. As the location of the cyst was located at the base of the brain, in the region of the third ventricle, it would be difficult to perform the surgery in the treatment of this case. Signs of ataxia, walking movements, decreased reflexes, nystagmus, unilateral blindness and lateral decubitus are commonly observed. Reports described that the main neurological alterations observed in 20 sheep with cenurosis were postural deficit, locomotion alteration, visual deficit and behavioral alterations, with more than 50% of the animals showing at least one of these signs. The main neurological signs observed in the case described were changes in gait, with walking, blindness, lateral head deviation and ataxia. These signs guide the clinical diagnosis of cenurosis. At necropsy, a spherical translucent cyst with approximately 4 cm in diameter was observed, containing the protoescolex/scolices of Taenia multiceps, which extended dorsally from the third ventricle to the base of the thalamus, laterally displaced to the right side. Rostrocaudal the lesion extended rostrally across the entire length of the thalamus to the beginning of the caudate nucleus and caudally to the base of the caudal colliculus, causing compression of the adjacent parenchyma, enabling the diagnosis of cenurosis. Similar findings are described as Coenurus cerebralis. This lesion pattern macroscopically characterizes the parasite lesions. Thus, it is concluded that the visualization of a hypodense area in CNS regions of sheep with neurological signs allows the diagnosis of cenurosis and precise location of the lesion. The description of this case adds information so that other professionals in the field can be successful in diagnosing the disease.


Subject(s)
Animals , Taeniasis/veterinary , Cysticercosis/veterinary , Sheep/parasitology , Central Nervous System Diseases/parasitology , Cestode Infections/veterinary , Cestode Infections/diagnostic imaging , Tomography, X-Ray Computed/veterinary
2.
Curr Pharm Des ; 25(37): 3983-3996, 2019.
Article in English | MEDLINE | ID: mdl-31612822

ABSTRACT

BACKGROUND: Parasitic infections affecting the central nervous system (CNS) present high morbidity and mortality rates and affect millions of people worldwide. The most important parasites affecting the CNS are protozoans (Plasmodium sp., Toxoplasma gondii, Trypanosoma brucei), cestodes (Taenia solium) and free-living amoebae (Acantamoeba spp., Balamuthia mandrillaris and Naegleria fowleri). Current therapeutic regimens include the use of traditional chemicals or natural compounds that have very limited access to the CNS, despite their elevated toxicity to the host. Improvements are needed in drug administration and formulations to treat these infections and to allow the drug to cross the blood-brain barrier (BBB). METHODS: This work aims to elucidate the recent advancements in the use of nanoparticles as nanoscaled drug delivery systems (NDDS) for treating and controlling the parasitic infections that affect the CNS, addressing not only the nature and composition of the polymer chosen, but also the mechanisms by which these nanoparticles may cross the BBB and reach the infected tissue. RESULTS: There is a strong evidence in the literature demonstrating the potential usefulness of polymeric nanoparticles as functional carriers of drugs to the CNS. Some of them demonstrated the mechanisms by which drugloaded nanoparticles access the CNS and control the infection by using in vivo models, while others only describe the pharmacological ability of these particles to be utilized in in vitro environments. CONCLUSION: The scarcity of the studies trying to elucidate the compatibility as well as the exact mechanisms by which NDDS might be entering the CNS infected by parasites reveals new possibilities for further exploratory projects. There is an urgent need for new investments and motivations for applying nanotechnology to control parasitic infectious diseases worldwide.


Subject(s)
Blood-Brain Barrier , Central Nervous System Diseases/drug therapy , Drug Delivery Systems , Nanoparticles , Parasitic Diseases/drug therapy , Central Nervous System Diseases/parasitology , Humans , Nanotechnology
3.
PLoS One ; 12(4): e0175588, 2017.
Article in English | MEDLINE | ID: mdl-28419136

ABSTRACT

Zoonotic visceral leishmaniasis is caused by the protozoan Leishmania infantum and little is known about the occurrence and pathogenesis of this parasite in the CNS. The aims of this study were to evaluate the occurrence, viability and load of L. infantum in the CNS, and to identify the neurological histological alterations associated with this protozoan and its co-infections in naturally infected dogs. Forty-eight Leishmania-seropositive dogs from which L. infantum was isolated after necropsy were examined. Cerebrospinal fluid (CSF) samples were analyzed by parasitological culture, quantitative real-time PCR (qPCR) and the rapid immunochromatographic Dual Path Platform test. Brain, spinal cord and spleen samples were submitted to parasitological culture, qPCR, and histological techniques. Additionally, anti-Toxoplasma gondii and anti-Ehrlichia canis antibodies in serum and distemper virus antigens in CSF were investigated. None of the dogs showed neurological signs. All dogs tested positive for L. infantum in the CNS. Viable forms of L. infantum were isolated from CSF, brain and spinal cord in 25% of the dogs. Anti-L. infantum antibodies were detected in CSF in 61% of 36 dogs. Inflammatory histological alterations were observed in the CNS of 31% of the animals; of these, 66% were seropositive for E. canis and/or T. gondii. Amastigote forms were associated with granulomatous non-suppurative encephalomyelitis in a dog without evidence of co-infections. The highest frequency of L. infantum DNA was observed in the brain (98%), followed by the spinal cord (96%), spleen (95%), and CSF (50%). The highest L. infantum load in CNS was found in the spinal cord. These results demonstrate that L. infantum can cross the blood-brain barrier, spread through CSF, and cause active infection in the entire CNS of dogs. Additionally, L. infantum can cause inflammation in the CNS that can lead to neurological signs with progression of the disease.


Subject(s)
Central Nervous System Diseases/veterinary , Dog Diseases/parasitology , Leishmania infantum/physiology , Leishmaniasis, Visceral/veterinary , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Antibodies, Protozoan/blood , Antibodies, Protozoan/immunology , Central Nervous System/parasitology , Central Nervous System/pathology , Central Nervous System Diseases/cerebrospinal fluid , Central Nervous System Diseases/parasitology , Coinfection/microbiology , Coinfection/parasitology , Coinfection/veterinary , DNA, Protozoan/genetics , Dog Diseases/microbiology , Dogs , Ehrlichia canis/immunology , Ehrlichia canis/physiology , Ehrlichiosis/microbiology , Ehrlichiosis/veterinary , Host-Parasite Interactions , Host-Pathogen Interactions , In Situ Hybridization , Leishmania infantum/genetics , Leishmania infantum/immunology , Leishmaniasis, Visceral/cerebrospinal fluid , Leishmaniasis, Visceral/parasitology , Parasite Load , Real-Time Polymerase Chain Reaction , Toxoplasma/immunology , Toxoplasma/physiology , Toxoplasmosis/parasitology
4.
Handb Clin Neurol ; 114: 229-34, 2013.
Article in English | MEDLINE | ID: mdl-23829913

ABSTRACT

Strongyloides stercoralis is a nematode endemic in humid tropical regions. The life cycle of this parasite is complex and unique due to its capacity to cause autoinfection, resulting in chronic infections. Innate and adaptive immune responses are responsible for clearing the parasite. Many risk factors have been described, but the most important is living in or having visited an endemic area. The clinical presentation of strongyloidiasis is varied and ranges from asymptomatic chronic infection to hyperinfection syndrome. Hyperinfection syndrome is more common in patients with immunosuppresion due to therapy with corticosteroids, coinfection with human T-lymphotropic virus type I (HTLV-1), transplant patients, or patients receiving chemotherapy. Multiplication and migration of large parasite numbers cause worsening of the initial symptoms and leads to a high mortality rate. CNS involvement in strongyloidiasis has only been seen in patients with hyperinfection syndrome. Meningitis is the most common form of CNS involvement and gram-negative bacteria are the more frequent etiology. Repeated stool samples with concentration methods have a good sensitivity and specificity. In patients that are not from endemic areas serum antibody tests may be useful in the diagnosis. Treatment with a single dose of ivermectin is recommended for most patients. In severe or hyperinfection cases repeated doses may be needed.


Subject(s)
Central Nervous System Diseases/etiology , Central Nervous System Diseases/parasitology , Strongyloides stercoralis/pathogenicity , Strongyloidiasis/complications , Animals , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/therapy , Humans , Strongyloidiasis/diagnosis , Strongyloidiasis/immunology , Strongyloidiasis/therapy
5.
Int J STD AIDS ; 24(1): 70-2, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23512507

ABSTRACT

Isolated cerebellar mass lesion is an uncommon presentation of toxoplasmosis. The authors report one rare case in a 50-year-old HIV-infected male patient who presented with clipped speech, gait ataxia and incoordination. The cerebellar toxoplasmosis was suspected based on imaging findings, despite the atypical location. This case highlights the need for a high index of clinical suspicion among HIV-infected patients with neurological manifestations and suspicious neuroimaging findings.


Subject(s)
AIDS-Related Opportunistic Infections/complications , HIV Infections/complications , Toxoplasma/isolation & purification , Toxoplasmosis, Cerebral/complications , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Urinary/therapeutic use , Central Nervous System Diseases/complications , Central Nervous System Diseases/drug therapy , Central Nervous System Diseases/parasitology , Drug Therapy, Combination , HIV Infections/drug therapy , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Tomography, X-Ray Computed , Toxoplasmosis, Cerebral/drug therapy , Toxoplasmosis, Cerebral/pathology , Treatment Outcome
6.
Parasitol Res ; 111(5): 2099-107, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22868891

ABSTRACT

Trypanosoma cruzi causes a pan-infection, Chagas disease, in American mammals through fecal transmission by triatomine insects, resulting in an acute phase parasitemia with intracellularity mainly in the myocells and cells of the central nervous system (CNS).The parasites, due to the immune response, then decrease in number, characteristic of the life-long chronicity of the disease. We infected a mouse model with isolates obtained from reservoirs and vectors from rural and urban endemic areas in Venezuela. Intracellular proliferation and differentiation of the parasite in astrocytes, microglia, neurons, endothelial cells of the piarachnoid, cells of the Purkinje layer, and spinal ganglion cells, as well as extracellularly in the neuropil, were evaluated during the acute phase. Damages were identified as meningoencephalitis, astrocytosis, reactive microglia, acute neuronal degeneration by central chromatolysis, endothelial cell hyperplasia, edema of the neuropil, and satellitosis. This is the first time that satellitosis has been reported from a mammal infected with T. cruzi. Intracellular T. cruzi and inflammatory infiltrates were found in cardiac and skeletal myocytes and liver cells. No parasitism or alterations to the CNS were observed in the chronic mice, although they did show myocarditis and myocitis with extensive infiltrates. Our results are discussed in relation to hypotheses that deny the importance of the presence of tissue parasites versus the direct relationship between these and the damages produced during the chronic phase of Chagas disease. We also review the mechanisms proposed as responsible for the nervous phase of this parasitosis.


Subject(s)
Central Nervous System Diseases/parasitology , Chagas Disease/parasitology , Disease Models, Animal , Host-Parasite Interactions , Trypanosoma cruzi/pathogenicity , Animals , Central Nervous System/parasitology , Central Nervous System/pathology , Central Nervous System Diseases/pathology , Chagas Disease/pathology , Mice , Venezuela
7.
Vet Parasitol ; 182(2-4): 359-63, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-21664764

ABSTRACT

Here, we report an outbreak of Trypanosoma vivax-induced trypanosomosis in Brazilian hair sheep on a farm in Paraíba state, a non-endemic region in northeastern Brazilian. Of 306 total sheep, 240 showed clinical signs and 216 died. Clinical signs included anorexia, lethargy, anemia, rough hair coat, weight loss, submandibular edema, abortion, and in some cases, neurological signs such as head pressing, lateral recumbence, paddling movements and muscle tremors. T. vivax was identified by blood smear analysis and polymerase chain reaction (PCR). At necropsy, animals exhibited watery blood, pale tissue coloring, and the presence of liquid in the peritoneal cavity and pericardial sac. Histologically, nonsuppurative myocarditis and meningoencephalitis with areas of malacia were observed. After treatment, no parasites were detected by blood smear analysis or PCR. Cattle and buffalo that remained in the same pasture were also infected but presented with asymptomatic infections. Epidemiological data suggest that T. vivax was introduced to the farm and the susceptible flock by buffalos that were asymptomatic carriers of the infection; T. vivax was most likely transmitted by Tabanus spp. bites and also iatrogenically.


Subject(s)
Central Nervous System Diseases/veterinary , Sheep Diseases/parasitology , Trypanosoma vivax , Trypanosomiasis/veterinary , Animals , Buffaloes , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/parasitology , Central Nervous System Diseases/parasitology , Central Nervous System Diseases/pathology , Disease Outbreaks/veterinary , Sheep , Time Factors , Trypanosomiasis/parasitology
8.
Vet Immunol Immunopathol ; 136(3-4): 340-5, 2010 Aug 15.
Article in English | MEDLINE | ID: mdl-20430448

ABSTRACT

Canine visceral leishmaniasis is an important emerging disease with a multitude of clinical symptoms, including neurological alterations. Matrix metalloproteinases (MMP) are proteases implicated with the extracellular matrix remodelling and, within the central nervous system, these enzymes are involved with blood-brain-barrier disruption and inflammation. To establish the involvement of MMP-2 and -9 within the nervous tissue of dogs with spontaneous visceral leishmaniasis, fragments of nervous tissue from oligosymptomatic (n=9), symptomatic (n=8), neurological (n=12) and normal dogs (n=8) were subjected to zymographic and to immunohistochemical analysis. Immunohistochemistry evidenced MMP-2 staining in inflammatory cells inside and outside blood vessels. MMP-9 was found in endothelial cells and in the ependyma. Zymographic evaluation revealed only the latent forms of MMP-2 and -9 within the nervous tissue. ProMMP-9 activity in the infected animals was found higher than the normal dogs, but with no difference among the infected dogs. Oligosymptomatic dogs presented the highest proMMP-2 activity, followed by the symptomatic and then, by the neurological and the normal dogs. In summary, the nervous tissue compartment seems to be preserved in dogs with VL, due to the absence of active MMPs, even though the elevated levels of proMMP-2 and -9 would indicate a pro-inflammatory state in the brain.


Subject(s)
Central Nervous System Diseases/veterinary , Dog Diseases/parasitology , Leishmania donovani/immunology , Leishmaniasis, Visceral/virology , Matrix Metalloproteinase 2/immunology , Matrix Metalloproteinase 9/immunology , Animals , Central Nervous System Diseases/enzymology , Central Nervous System Diseases/immunology , Central Nervous System Diseases/parasitology , Dog Diseases/enzymology , Dog Diseases/immunology , Dogs , Electrophoresis, Polyacrylamide Gel/veterinary , Female , Immunohistochemistry/veterinary , Leishmaniasis, Visceral/enzymology , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/parasitology , Male , Statistics, Nonparametric
9.
Rev. chil. infectol ; Rev. chil. infectol;23(3): 237-242, sept. 2006. ilus, tab
Article in Spanish | LILACS | ID: lil-433433

ABSTRACT

Durante los últimos años, otra ameba de vida libre, Balamuthia mandrillaris, ha sido identificada como agente etiológico de meningoencefalitis granulomatosa amebiana (MGA) en humanos. Presentamos el caso de una escolar de sexo femenino, inmunocompetente en quien se realizó el diagnóstico post mortem de MGA por este agente. Consultó por aparición de lesiones eritematosas e induradas que comprometían la zona centro-facial. En biopsia cutánea se evidenció una lesión granulomatosa con RPC positiva para secuencias génicas de Mycobacterium atípico, por lo que se inició tratamiento para micobacteriosis atípica extrapulmonar. Evolucionó con compromiso neurológico progresivo, falleciendo aproximadamente un año después de iniciar los síntomas. La necropsia reveló una MGA, cuyo estudio posterior demostró la presencia de B. mandrillaris. La infección por B. mandrillaris debe ser considerada en el diagnóstico diferencial de una enfermedad granulomatosa crónica que evoluciona con compromiso neurológico.


Subject(s)
Humans , Female , Child , Amebiasis/diagnosis , Amebiasis/parasitology , Granuloma/parasitology , Lobosea , Meningoencephalitis/diagnosis , Meningoencephalitis/parasitology , Amoeba , Amebiasis/drug therapy , Diagnosis, Differential , Central Nervous System Diseases/parasitology , Erythema/parasitology , Fatal Outcome , Nose/pathology , Opportunistic Infections , Disease Progression
10.
Vet Immunol Immunopathol ; 113(1-2): 243-7, 2006 Sep 15.
Article in English | MEDLINE | ID: mdl-16828168

ABSTRACT

The protozoan Neospora caninum has a veterinary importance because it causes abortion in cattle and neuromuscular alterations in dogs. We infected rat astrocytes, in vitro, with different concentrations of N. caninum. Astrocytes responded to infection by producing the pro-inflammatory cytokine TNF-alpha and the neurotoxic-free radical NO, 24 and 72 h post-infection. These data suggest that astrocytes, which are essential for brain function, are targets for the parasite and this represents a practical and valid model to study the effects of N. caninum on the CNS.


Subject(s)
Astrocytes/parasitology , Central Nervous System Diseases/parasitology , Central Nervous System Diseases/veterinary , Coccidiosis/immunology , Neospora/immunology , Animals , Astrocytes/immunology , Astrocytes/metabolism , Cells, Cultured , Central Nervous System Diseases/immunology , Central Nervous System Diseases/metabolism , Chlorocebus aethiops , Coccidiosis/parasitology , Coccidiosis/veterinary , Immunohistochemistry/veterinary , Nitrites/metabolism , Rats , Tumor Necrosis Factor-alpha/metabolism , Vero Cells
11.
Am J Pathol ; 159(5): 1723-33, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11696433

ABSTRACT

The role of cytokines in the control of tissue parasitism and pathogenesis of experimental Chagas' disease was investigated. Wild-type and different cytokine as well as inducible nitric oxide synthase (iNOS) knockout mice were infected with the Colombian strain of Trypanosoma cruzi, and the kinetics of tissue parasitism, inflammatory reaction, parasitemia, and mortality were determined. We demonstrate the pivotal role of the interleukin (IL)-12/interferon (IFN)-gamma/iNOS axis and the antagonistic effect of IL-4 in controlling heart tissue parasitism, inflammation, and host resistance to acute infection with T. cruzi. Further, the heart and central nervous system were shown the main sites of reactivation of T. cruzi infection in mice lacking functional genes for IFN-gamma and IL-12, respectively. Our results also show that in contrast to IFN-gamma knockout (KO) mice, splenocytes from IL-12 KO mice infected with T. cruzi produced low levels of IFN-gamma upon stimulation with antigen. Consistently, high levels of anti-T. cruzi IgG2a antibodies were detected in the sera from IL-12 KO, but not from IFN-gamma KO mice, infected with the Colombian strain of T. cruzi. Thus, our results suggest that the level of IFN-gamma deficiency is a major determinant of the site of reactivation of T. cruzi infection in immunocompromised host.


Subject(s)
Central Nervous System Diseases/pathology , Central Nervous System Diseases/parasitology , Chagas Cardiomyopathy/pathology , Chagas Cardiomyopathy/parasitology , Chagas Disease/pathology , Chagas Disease/parasitology , Interferon-gamma/physiology , Interleukin-12/physiology , Animals , Central Nervous System/parasitology , Central Nervous System/pathology , Disease Susceptibility , Female , Heart/parasitology , Interferon-gamma/deficiency , Interferon-gamma/genetics , Interleukin-12/deficiency , Interleukin-12/genetics , Interleukin-4/deficiency , Interleukin-4/genetics , Interleukin-4/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout/genetics , Myocarditis/parasitology , Myocarditis/pathology , Myocardium/pathology , Nitric Oxide Synthase/deficiency , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/physiology , Nitric Oxide Synthase Type II , Recurrence
12.
Acta Trop ; 77(1): 101-9, 2000 Oct 23.
Article in English | MEDLINE | ID: mdl-10996126

ABSTRACT

The literature on the assessment of morbidity due to Schistosoma mansoni infection is updated. Imaging techniques such as ultrasonography, echodoppler cardiography, computerized tomography (CT scan) and magnetic resonance imaging (MRI) introduced a new perspective, and expanded our knowledge on morbidity. Three well-defined syndromes caused by schistosomiasis mansoni have been described: the stage of invasion, acute schistosomiasis (Katayama fever), and chronic schistosomiasis. Complications of the acute and chronic syndromes have also been reported: pulmonary hypertension, neuroschistosomiasis, association with Salmonella, association with Staphylococci, viral hepatitis B, glomerulonephritis. In most individuals with hepatosplenic schistosomiasis the spleen is increased in size. Hepatosplenic schistosomiasis can, however, occur without splenomegaly. The definition of hepatosplenic schistosomiasis in endemic areas as the finding of S. mansoni eggs in the stools in an individual with hepatosplenomegaly is not satisfactory anymore. Many aspects of morbidity are expected to change after schistosomiasis control. Some are expected to change quickly (worm burden, Salmonella bacteremia, hepatosplenic schistosomiasis in children) whereas others shall remain for years (pulmonary hypertension, glomerulonephritis, neuroschistosomiasis). Intestinal schistosomiasis in individuals with low worm burdens is very difficult to diagnose and therefore laborious to control.


Subject(s)
Communicable Disease Control , Schistosomiasis mansoni/epidemiology , Brazil/epidemiology , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/parasitology , Glomerulonephritis/complications , Hepatitis B/complications , Humans , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/diagnosis , Intestinal Diseases/diagnosis , Intestinal Diseases/parasitology , Liver Diseases/diagnosis , Liver Diseases/parasitology , Magnetic Resonance Imaging , Morbidity , Salmonella Infections/complications , Schistosomiasis mansoni/complications , Schistosomiasis mansoni/diagnosis , Splenic Diseases/diagnosis , Splenic Diseases/parasitology , Staphylococcal Infections/complications , Tomography , Ultrasonography
13.
Rev. mex. radiol ; 53(1): 3-8, ene.-mar. 1999. tab, ilus
Article in Spanish | LILACS | ID: lil-266307

ABSTRACT

Revisaron los expedientes clínicos y estudios de Tomografía Computada (TC) de 71 pacientes con diagnóstico de neurocisticercosis con el fin de valorar la edad de presentación, los síntomas predominantes, la utilidad de la TC y el tipo de lesión más frecuente. La edad de los pacientes estuvo en el rango de 1 a 18 años por lo que se infiere que la edad no excluye el diagnóstico. Se encontró que los síntomas clínicos más comunes fueron las crisis convulsivas y la cefalea. La CT fue anormal en 93 por ciento de los pacientes lo que confirma que este estudio sigue siendo de gran utilidad, sobre todo en países en desarrollo en donde no se cuenta con resonancia magnética. La lesión que predominó fue la parenquimatosa y de ésta, la variedad encefalítica, lo que concuerda con lo informado en la literatura


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Adolescent , Cysticercosis , Central Nervous System Diseases/parasitology , Central Nervous System Diseases , Tomography, X-Ray Computed
14.
Arq Neuropsiquiatr ; 55(1): 8-11, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9332554

ABSTRACT

The detection of IgE is technically difficult because of its reduced concentrations in serum, and even lower concentrations in cerebrospinal fluid (CSF). In the present investigation we studied 86 CSF samples using an immunoenzymatic method with an anti-IgE-alkaline phosphatase conjugate and a fluorigenic substrate. The samples were from three groups: A) 29 patients with neurocysticercosis (NC), B) 36 patients with different neurologic disorders (neurosyphilis, neurotuberculosis, meningitis, tumors, hemorrhage) and C) 21 discharged individuals who had been hospitalized for bacterial meningitis. The results obtained were: A) 0.05 to 3.00 IU/ml (0.76 +/- 0.79), B) 0.00 to 1.50 IU/ml (0.23 +/- 0.34) and C) 0.05 to 1.25 IU/ml (0.34 +/- 0.34). The present results suggest that IgE appears to play a role in the pathogeny of NC and that efforts should be made to standardize a test for the detection of specific IgE antibodies.


Subject(s)
Central Nervous System Diseases/cerebrospinal fluid , Central Nervous System Diseases/parasitology , Cysticercosis/cerebrospinal fluid , Immunoglobulin E/cerebrospinal fluid , Central Nervous System Diseases/immunology , Cysticercosis/immunology , Humans
15.
Brain Pathol ; 7(1): 673-9, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9034573

ABSTRACT

Echinococcosis is a human disease caused by the larval form of Taenia echinococcus, which lives in the gut of the dog, wild canides and other carnivorous animals which represent the definitive hosts and involves as intermediate hosts both domestic and wild animals. Humans become accidental intermediate hosts by ingesting Taenia eggs. The main species pathogenic for man are E granulosus causing cystic echinococcosis with worldwide distribution and endemic in sheep and cattle breeding countries, and E multilocularis causing alveolar echinococcosis, with preferential distribution in the northern hemisphere. After ingestion of contaminated food, hexacanth embryos migrate by the portal system to liver and later lung, brain and other tissues. Symptoms are related to both cyst location and size. E granulosus infection of the central nervous system (CNS) may be primary or secondary and has been estimated to be low (2%). Sharply demarcated, spherical and intraparenchymal, cysts may reach a large size causing neurological symptoms. Spilling of cyst fluid due to trauma or surgery may trigger anaphylaxis as well as disseminated infection. Host reaction is minimal in the brain but a foreign giant cell reaction may develop. E multilocularis develops within the liver as a rapid invasive pseudomalignant growth and may metastasize to the CNS, where estimated incidence reaches 5%. Hydatid antigens induce an immune reaction in the host which is helpful for the diagnosis. DNA probes and PCR may be applied to differentiate between Echinococcus spp. Although the host develops an immunological protection from reinfection, the parasite evades host immune attack. A wide range of evasion mechanisms have been advanced, including a barrier for host cells due to hydatid cyst laminated cuticle, polyclonal activation of lymphocytes by parasite soluble antigens, and depression of host cell immune responses. Chronic stimulation of the host by cyst fluid antigens leads to increased specific IgG4 production, which might act as blocking antibodies against anaphlaxis suggestive of host response immunomodulation.


Subject(s)
Echinococcosis/parasitology , Taenia/physiology , Animals , Central Nervous System Diseases/parasitology , Echinococcosis/diagnosis , Echinococcosis/epidemiology , Echinococcosis/physiopathology , Host-Parasite Interactions , Humans , Immunologic Tests , Zoonoses
16.
Brain Pathol ; 7(1): 681-93, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9034574

ABSTRACT

Cysticercosis is an infection caused by Taenia solium larvae (cysticerci). When the cysticercus is lodged in the central nervous system (CNS), the disease is known as neurocysticercosis (NCC). NCC is the most frequent and most widely disseminated human neuroparasitosis. It is endemic in many parts of the world, particularly Latin America, Africa, and Asia, and still relatively frequent in Portugal, Spain and Eastern European countries It is also endemic in developed countries with high rates of immigration from endemic areas. Man may act as an intermediate host after ingestion of mature, viable T. solium eggs via the fecal-oral route. The development of lesions in the brain and leptomeninges, and the consequent of onset of symptoms associated with NCC are mainly due to the host immune-inflammatory response. As long as the cysticercus remains viable, there is relative host immune tolerance. It is only when the parasite dies that massive antigen exposure occurs, with intensification of the immune response/inflammatory reaction and the appearance or worsening of symptoms. NCC can be asymptomatic or cause widely varied clinical manifestations, such as seizures, increased intracranial pressure, ischemic cerebrovascular disease, dementia, and signs of compression of the spinal roots/cord. The combination of two or more symptoms is common. Such clinical polymorphism is determined by 1) the number of lesions (single or multiple cysticerci); 2) the location of CNS lesions (subarachnoid, intracerebral, intraventricular, intramedullary); 3) the type of cysticercus (Cysticercus cellulosae, Cysticercus racemosus); 4) the stage of development and involution of the parasite (vesicular or viable, necrotic, fibrocalcified nodule); and 5) the intensity of the host immune-inflammatory response (no inflammatory reaction, leptomeningitis, encephalitis, granular ependymitis, arteritis).


Subject(s)
Central Nervous System Diseases/parasitology , Cysticercosis/parasitology , Taenia/physiology , Animals , Central Nervous System Diseases/epidemiology , Central Nervous System Diseases/pathology , Cysticercosis/epidemiology , Cysticercosis/pathology , Cysticercosis/physiopathology , Host-Parasite Interactions , Humans , Mexico/epidemiology
17.
Arq Neuropsiquiatr ; 54(4): 565-70, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9201335

ABSTRACT

Neurocysticercosis is the central nervous system infestation by Cysticercus cellulosae, the larval form of Taenia solium. It is related to poor hygiene habits and sanitation; although Northeast is poorest Region of Brazil, it has been always stated as a non-endemic area. After the installation of computed tomography (CT) service, the incidence of neurocysticercosis began to raise in neurology services in Campina Grande PB, a city where people from the interior Paraíba can find specialized medical facilities. We analyse 5,883 CT record of the TomoHPI Computed Tomography Service from August 1993 to December 1995, observing 1.02% suggestive neurocysticercosis cases and classified them according to sex and age, procedence and socioeconomic condition. Distribution of cases according to age is homogeneous until the age of 50 (mean: 28.36 years old). Men and women are equally affected. Urban areas inhabitants represented 83.33%. Residents of Campina Grande represented 48.33% and 48.34% were residents of cities around Campina Grande (until 50 Km around) and other cities of Paraíba State. Fifty-eight patients were dependent to public health care system. We conclude that neurocysticercosis seems to be endemic in Paraiba State, demanding a more detailed study to determine its incidence/prevalence.


Subject(s)
Central Nervous System Diseases/epidemiology , Central Nervous System Diseases/parasitology , Cysticercosis/epidemiology , Endemic Diseases , Adolescent , Adult , Age Distribution , Aged , Brazil , Central Nervous System Diseases/diagnostic imaging , Child , Child, Preschool , Cysticercosis/diagnostic imaging , Female , Humans , Infant , Male , Middle Aged , Socioeconomic Factors , Tomography, X-Ray Computed
18.
Pediatría (Santiago de Chile) ; 39(3/4): 110-4, jul.-dic. 1996.
Article in Spanish | LILACS | ID: lil-202520

ABSTRACT

La neurocisticercosis es la parasitosis del sistema nervioso central (SNC) producida por la forma larval de la taenia solium. En 1950 Parnolus encontró un cisticerco en el cuerpo calloso, pero sólo en 1985 Kuchen Meister asoció afección con la taenia solium. La forma muscular fue descubierta por primera vez por Priets en 1926 y subsecuentemente también la comunicaron M Gill, Jacob y Mathews. En Estados Unidos la neurocisticercosis se describió por primera vez en 1927 por Walter Dandy


Subject(s)
Humans , Central Nervous System Diseases/parasitology , Cysticercosis/diagnosis , Albendazole/therapeutic use , Cysticercosis/classification , Cysticercosis/drug therapy , Cysticercosis/physiopathology , Dexamethasone/therapeutic use , Praziquantel/therapeutic use , Taenia/drug effects , Taenia/pathogenicity
19.
Arq Neuropsiquiatr ; 54(1): 107-13, 1996 Mar.
Article in Portuguese | MEDLINE | ID: mdl-8736154

ABSTRACT

Report of a patient with the hydrocephalic and meningoencephalitic form of neurocysticercosis who simultaneously developed polyradiculoneuropathy and intracranial hypertension syndrome during the first week of treatment with albendazole. Etiologic agents associated with polyradiculoneuropathy related in the literature are cited. Some comments about the possible physiopathogeny of this entity in the presence of cysticercosis are also done. It is mentioned another case who presented polyradiculoneuropathy as the only manifestation of a probable cysticercosis of the nervous system. In this presented case, including the neurocysticercosis and even a mere coincidence of facts, some factors can have a relationship with the appearance of polyradiculoneuropathy as the surgical stress, the stress due to the severity of the clinical picture and the possible side effect of albendazole.


Subject(s)
Albendazole/adverse effects , Anthelmintics/adverse effects , Central Nervous System Diseases/drug therapy , Central Nervous System Diseases/parasitology , Cysticercosis/drug therapy , Polyradiculoneuropathy/chemically induced , Adult , Cysticercosis/complications , Humans , Male
20.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;54(1): 82-93, mar. 1996. tab, ilus
Article in English | LILACS | ID: lil-164059

ABSTRACT

Study of 22 patients with the severe form of neurocysticercosis treated with albendazole (ABZ) administered in 6 different schedules ranging from 15 to 30 mg/kg/day for 21 to 60 days. Dextrochloropheniramine and ketoprofen were the adjuvant drugs. Multiple symptoms were observed in 90.9 per cent of patients. Intracranial hypertension was manifested in 90.9 per cent. Hydrocephaly occurred in 86.4 per cent. Evolution was satisfactory in 10 patients, 8 died and 4 had sequelae. Tomographic studies showed the appearance of an isolated IVth ventricle in 9 patients, after ventriculoperitoneal shunt, before ABZ treatment in 3 of them, during in 5 and after treatment in one. Median clinical follow-up duration was 10 months for the patients who died and 3-4 years for survivors. In 3 patients there was an increase in cyst size during the administration of the 15 mg/kg/day ABZ dose, which was not observed in any patient when the 30 mg/kg/day dose was used.


Subject(s)
Humans , Male , Female , History, Ancient , Adolescent , Adult , Middle Aged , Albendazole/therapeutic use , Cysticercosis/drug therapy , Central Nervous System Diseases/parasitology , Ketoprofen/therapeutic use , Pheniramine/therapeutic use , Acetazolamide/therapeutic use , Albendazole/administration & dosage , Cysticercosis/cerebrospinal fluid , Cysticercosis/diagnosis , Cysticercosis/surgery , Central Nervous System Diseases/diagnosis , Central Nervous System Diseases/drug therapy , Prognosis , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL